Antti Poso

Citado por

	Total	Desde 2020
Citas	8415	3696
Índice h	53	27
Índice i10	170	92

920

460

230

690

1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202524 43 24 33 36 30 57 52 106 154 192 310 327 275 294 297 271 290 323 367 302 386 439 506 589 744 779 905 166

Acceso público

Ver todo

91 artículos

20 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Agnieszka A. KaczorMedical University of LublinDirección de correo verificada de umlub.pl
Outi M. H. Salo-AhenAdjunct Professor (Docent), Senior University Lecturer, Åbo Akademi UniversityDirección de correo verificada de abo.fi
Erik A. A. WallénUniversity of HelsinkiDirección de correo verificada de helsinki.fi
Paavo HonkakoskiUniversity of Eastern Finland, School of PharmacyDirección de correo verificada de uef.fi
Regina Hofmann-LehmannClinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical StudiesDirección de correo verificada de vetclinics.uzh.ch
Jayendra Z. PatelPostdocDirección de correo verificada de helsinki.fi
Tarja KokkolaUniversity of Eastern FinlandDirección de correo verificada de uef.fi
Tommi Henrik NyrönenCSC - IT Center for Science Ltd.Dirección de correo verificada de csc.fi
Pekka T. Männistöprofessor of pharmacology and drug development (emer.)Dirección de correo verificada de fimnet.fi
Stephen HiltonUniversity College LondonDirección de correo verificada de ucl.ac.uk
Prasanthi MedarametlaUniversity of Eastern FinlandDirección de correo verificada de uef.fi
Pekka TiikkainenBayer PharmaceuticalsDirección de correo verificada de bayer.com
Johannes ChristiaansProfessor, Institute of Chemistry, Tartu University, EstoniaDirección de correo verificada de ut.ee
Miia TurpeinenUniversity of OuluDirección de correo verificada de oulu.fi
Krister WennerbergBRIC, University of CopenhagenDirección de correo verificada de fimm.fi
Ari KoskinenEmeritus Professor of Organic Chemistry, Aalto UniversityDirección de correo verificada de aalto.fi
Holger GrohganzAssociate Professor, University of CopenhagenDirección de correo verificada de sund.ku.dk
Anna-Liisa LevonenUniversity of Eastern FinlandDirección de correo verificada de uef.fi
Emilia KansanenDirección de correo verificada de uef.fi
Igor O. KoshevoyUniversity of Eastern FinlandDirección de correo verificada de uef.fi

Seguir

Antti Poso

Professor of Drug Design, University of Eastern Finland

Dirección de correo verificada de uef.fi

Drug design


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Binding affinity via docking: fact and fiction T Pantsar, A Poso Molecules 23 (8), 1899, 2018	608	2018
A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer D Dauch, R Rudalska, G Cossa, JC Nault, TW Kang, T Wuestefeld, ... Nature medicine 22 (7), 744-753, 2016	301	2016
DeepCDA: deep cross-domain compound–protein affinity prediction through LSTM and convolutional neural networks K Abbasi, P Razzaghi, A Poso, M Amanlou, JB Ghasemi, ... Bioinformatics 36 (17), 4633-4642, 2020	213	2020
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes SM Saario, OMH Salo, T Nevalainen, A Poso, JT Laitinen, T Järvinen, ... Chemistry & biology 12 (6), 649-656, 2005	196	2005
An in silico approach to discovering novel inhibitors of human sirtuin type 2 AJ Tervo, S Kyrylenko, P Niskanen, A Salminen, J Leppänen, TH Nyrönen, ... Journal of medicinal chemistry 47 (25), 6292-6298, 2004	138	2004
Prediction of human population responses to toxic compounds by a collaborative competition. Nature Biotechnology 33, 933-940, 2015	122	2015
Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase N Aaltonen, JR Savinainen, CR Ribas, J Rönkkö, A Kuusisto, J Korhonen, ... Chemistry & biology 20 (3), 379-390, 2013	121	2013
Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization M Ammad-Ud-Din, E Georgii, M Gonen, T Laitinen, O Kallioniemi, ... Journal of chemical information and modeling 54 (8), 2347-2359, 2014	118	2014
Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors T Huhtiniemi, T Suuronen, VM Rinne, C Wittekindt, M Lahtela-Kakkonen, ... Journal of medicinal chemistry 51 (15), 4377-4380, 2008	108	2008
Development of a 3D model for the human cannabinoid CB1 receptor OMH Salo, M Lahtela-Kakkonen, J Gynther, T Järvinen, A Poso Journal of medicinal chemistry 47 (12), 3048-3057, 2004	106	2004
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells D Rotili, D Tarantino, A Nebbioso, C Paolini, C Huidobro, E Lara, P Mellini, ... Journal of medicinal chemistry 55 (24), 10937-10947, 2012	105	2012
Deep learning in drug target interaction prediction: current and future perspectives K Abbasi, P Razzaghi, A Poso, S Ghanbari-Ara, A Masoudi-Nejad Current Medicinal Chemistry 28 (11), 2100-2113, 2021	99	2021
Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands A Poso, JW Huffman British journal of pharmacology 153 (2), 335-346, 2008	91	2008
Predictive three-dimensional quantitative structure− activity relationship of cytochrome P450 1A2 inhibitors LE Korhonen, M Rahnasto, NJ Mähönen, C Wittekindt, A Poso, ... Journal of medicinal chemistry 48 (11), 3808-3815, 2005	91	2005
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery X Liu, S Huuskonen, T Laitinen, T Redchuk, M Bogacheva, K Salokas, ... Molecular Systems Biology 17 (11), e10396, 2021	87	2021
Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands KH Raitio, OMH Salo, T Nevalainen, A Poso, T Jarvinen Current medicinal chemistry 12 (10), 1217-1237, 2005	87	2005
Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling T Pantsar, S Rissanen, D Dauch, T Laitinen, I Vattulainen, A Poso PLoS computational biology 14 (9), e1006458, 2018	85	2018
Transcription and translation inhibitors in cancer treatment N Laham-Karam, GP Pinto, A Poso, P Kokkonen Frontiers in Chemistry 8, 276, 2020	84	2020
A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor C Navajas, T Kokkola, A Poso, N Honka, J Gynther, JT Laitinen European journal of pharmacology 304 (1-3), 173-183, 1996	84	1996
The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening T Kalliokoski, HS Salo, M Lahtela-Kakkonen, A Poso Journal of chemical information and modeling 49 (12), 2742-2748, 2009	80	2009

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores